Restylane Eyelight Receives FDA Approval for Under-eye Rejuvenation
| ABCS
Galderma recently announced the newest dermal filler in the Restylane® family of fillers, Eyelight™, has received FDA approval to improve the appearance of depressed, sunken, or hollow areas under the eyes (infraorbital hollowing).
Here’s what you need to know about Restylane Eyelight.
What is Restylane Eyelight?
Restylane Eyelight is the newest injectable hyaluronic acid (HA) filler to treat volume loss under the eyes for adults over 21. Hollow tear troughs often create the appearance of under eye bags and emphasize dark circles that cause a fatigued, aged look, and dermal filler minimizes their appearance by adding volume beneath the skin.
Related:
- The FDA Approves Juvéderm Volbella XC for Under-Eye Treatment
- Juvéderm Skinvive, the First Microdroplet Injectable, Receives FDA Approval
- Can You “Un-Do” Dermal Fillers?
What makes Restylane Eyelight Unique?
Restylane Eyelight is currently the first and only product in the United States formulated with Non-Animal Stabilized Hyaluronic Acid (NASHA®). This new generation of HA (a naturally occuring substance in the body) is minimally cross-linked and produced without animal by-products and is instead manufactured using bacterial proteins.
Because it does not contain animal by-products, Restylane Eyelight is thought to offer longer-lasting results due to a lower immune response compared to traditional HA dermal fillers. The body’s immune system may be slower to naturally break down and process the material, thus extending its rejuvenating effects.
Restylane Eyelight is the first and only HA dermal filler to use NASHA technology.
Results of Restylane Eyelight’s clinical trials
The safety and efficacy data from a randomized, blinded, multi-center Phase 3 study showed:
- 87% of patients had reduced under-eye hollowness at 3 months
- 92% of patients were pleased with their results at 3 months
- 84% were still pleased with their results at 12 months
- 93% of patients said they would receive the treatment again after 12 months
Restylane Eyelight was well tolerated under the eyes, with 87% of patients experiencing no adverse side effects. The most common side effects reported from the undereye filler were redness, swelling, itching, bruising, pain, tenderness, and lumps or bumps at the injection site. These side effects were generally mild, and none were severe. No incidents of blue discoloration (Tyndall effect) were observed after Restylane Eyelight treatments.
When will Restylane Eyelight be available?
Restylane Eyelight will be available at aesthetic practices “over the next several months,” according to a June 2023 press release.
How to choose the right provider for cosmetic injectables
Your safety and satisfaction with cosmetic treatments depend on your choice of provider. Although cosmetic injections seem relatively straightforward, achieving optimal results requires extensive knowledge of underlying anatomy, a thorough understanding of the products used, and an eye for aesthetics. When considering a tear trough filler like Restylane Eyelight or any other injectable treatment, choose a board-certified cosmetic surgeon or a qualified injector with specific training in facial injectables overseen by a board-certified cosmetic surgeon.
Why trust a board-certified cosmetic surgeon?
Cosmetic surgeons certified by the American Board of Cosmetic Surgery (ABCS) have extensive training in a full range of cosmetic treatments and procedures, including cosmetic injectables, and they pledge themselves to uphold the highest standards of care. Board-certified cosmetic surgeons are dedicated to staying abreast of the latest products and technologies to provide patients with safe, natural results.